Trademark: 79308667
Word
D DEMENTIA DISCOVERY FUND
Status Date
Tuesday, April 19, 2022
Registration Number
6703551
Registration Date
Tuesday, April 19, 2022
Filing Date
Monday, September 9, 2019
Published for Opposition
Tuesday, February 1, 2022
5 Pharmaceutical and medical preparations and substances for the treatment of dementia; Pharmaceutical and medical preparations and substances for use in the treatment and prevention of dementia; Sanitary preparations for medical purposes; Pharmaceutical preparations, all for use in the treatment and prevention of brain diseases and degenerative dementia disorders; Antiseptic preparations; Prescription pharmaceuticals for humans as well as other pharmaceutical products for the treatment of dementia; Dietetic foods adapted for medical use, and dietary and health food supplements; Vitamins; Dietetic substances adapted for medical use, namely, food for babies, teens, adults, and elders; Homeopathic preparations and substances for the treatment of dementia; Medicated drinks; Anti-diabetic drugs; Hypertension medications; Steroid hormones; Non-steroidal anti-inflammatory drugs
36 Insurance agency and brokerage; Financial affairs and monetary affairs, namely, financial information, management, and analysis services; Real estate agency services; Financial services, namely, financing the medical research of others; Arranging of financing for humanitarian aid and development, including charitable fundraising and support services for research in dementia; Charitable fundraising regarding funding for dementia research; Charitable services, namely, providing financial assistance to disadvantaged persons for food, clothing, and health care; Financial sponsorship services of charitable musical entertainment, running and walking, food tasting, dinner and dance events; Financial services, namely, managing and monitoring of charitable funds supporting dementia research; Accepting and administering monetary charitable contributions, namely, distribution and allocation of charitable funds; Providing of information in the field of charitable monetary giving through corporate donations and payroll donations by employees; Information, advisory, and consultancy services in relation to the aforesaid services
44 Medical services; The provision of information, online via the Internet, on the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; Medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; Medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; Medical services concerning dementia, namely, physician, nursing, midwifery, and hospital services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Hygienic and beauty care for human beings; Agricultural advice services; Dentistry services; Medical analysis for the diagnosis and treatment of individuals and groups of people with dementia related to x-ray examinations and taking blood samples; Pharmaceutical advice; Medical clinic services; Medical treatment services; Medical analysis services; Nursing services; Information, advisory, and consultancy services relating to all the aforesaid
42 Scientific and technological services, namely, research and design in the field of goods and services connected with dementia treatment; Scientific and technological services, namely, research and design in the field of goods and services connected with dementia; Industrial analysis and research services in the field of goods and services connected with dementia treatment to assure compliance with industry standards; Design and development of computer hardware and software; Design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of goods and services connected with dementia treatment; Laboratory research in the field of goods and services connected with dementia treatment; Laboratory research services in the field of goods and services connected with dementia treatment; Scientific and technological services, namely, laboratory testing services in the field of goods and services connected with dementia treatment; Medical laboratory services; Medical and scientific research services in relation to the causes, symptoms, diagnosis, treatment and prevention of dementia; Genetic research concerning dementia; Provision of medical and scientific research facilities; Medical and scientific research laboratories; Medical and scientific research in relation to medicines and pharmaceuticals; Medical research services; Design and development of software in the field of mobile device applications; Design and development of computer programmes
The mark consists of the dark blue stylized wording "DEMENTIA" above the light blue stylized wording "DISCOVERY" above the green stylized wording "FUND", all to the right of a stylized letter "D" represented by multiple shaded dots colored in various shades of green, light blue, dark blue, and purple and connected by gray lines arranged to form triangular outlines. The color white appearing in the mark represents background and is not claimed as a feature of the mark.
The color(s) dark blue, light blue, green, purple, and gray is/are claimed as a feature of the mark.
"DEMENTIA DISCOVERY FUND"
Sep 26, 2022
Final Decision Transaction Processed By Ib
Sep 1, 2022
Final Disposition Notice Sent To Ib
Sep 1, 2022
Final Disposition Processed
Jul 19, 2022
Final Disposition Notice Created, To Be Sent To Ib
Apr 19, 2022
Registered-Principal Register
Feb 1, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2022
Published For Opposition
Jan 29, 2022
Notification Processed By Ib
Jan 12, 2022
Notification Of Possible Opposition Sent To Ib
Jan 12, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 12, 2022
Notification Of Notice Of Publication E-Mailed
Dec 29, 2021
Assigned To Lie
Dec 27, 2021
Approved For Pub - Principal Register
Dec 22, 2021
Teas/Email Correspondence Entered
Dec 22, 2021
Correspondence Received In Law Office
Dec 22, 2021
Teas Request For Reconsideration Received
Dec 3, 2021
Notification Of Final Refusal Emailed
Dec 3, 2021
Final Refusal E-Mailed
Dec 3, 2021
Final Refusal Written
Oct 23, 2021
Teas/Email Correspondence Entered
Oct 22, 2021
Correspondence Received In Law Office
Oct 22, 2021
Teas Response To Office Action Received
Jun 26, 2021
New Representative At Ib Received
May 31, 2021
Refusal Processed By Ib
May 3, 2021
Non-Final Action Mailed - Refusal Sent To Ib
May 3, 2021
Refusal Processed By Mpu
Apr 29, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Apr 28, 2021
Non-Final Action Written
Apr 20, 2021
Application Filing Receipt Mailed
Apr 16, 2021
Assigned To Examiner
Apr 16, 2021
New Application Office Supplied Data Entered In Tram
Apr 15, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
